Filter
4410
Filtered Results: 4410
Text search:
drug
therapy
Featured
Recommendations
406
New Publications
1125
Language
Document type
No document type
2776
Studies & Reports
609
Guidelines
585
Manuals
168
Strategic & Response Plan
100
Fact sheets
71
Training Material
51
Situation Updates
18
Infographics
13
Resource Platforms
9
Brochures
7
Online Courses
2
App
1
Countries / Regions
India
288
Kenya
124
Global
119
South Africa
116
Uganda
96
Ethiopia
95
Western and Central Europe
93
Nigeria
83
Tanzania
82
Nepal
77
Zambia
76
Sierra Leone
63
Malawi
62
Eastern Europe
58
Liberia
55
Latin America and the Carribbean
54
Ghana
53
Africa
53
Ukraine
52
Rwanda
50
Myanmar / Burma
50
Bangladesh
42
Namibia
41
Zimbabwe
37
Asia
36
Russia
36
Indonesia
35
Lesotho
33
Philippines
32
Cambodia
26
South–East Asia Region
23
Botswana
20
Senegal
19
Germany
17
Syria
16
Eswatini/ Swaziland
16
Burkina Faso
14
Mozambique
14
East and Southern Africa
13
USA
12
Albania
11
West and Central Africa
11
Middle East and North Africa
11
Brazil
11
Tajikistan
10
Colombia
10
Cameroon
10
Haiti
10
Congo, Democratic Republic of
10
South Sudan
10
Eastern Europe and Central Asia
9
Venezuela
8
Thailand
7
Sudan
7
Pakistan
7
Benin
6
Western Pacific Region
6
Argentina
6
Georgia
6
China
5
Afghanistan
5
Peru
5
Armenia
5
Iraq
5
North Macedonia
4
Guinea
4
Paraguay
4
United Kingdom
4
Spain
4
Bolivia
4
Vietnam
4
Moldova
4
Yemen
4
Bhutan
4
Timor Leste/ East Timor
3
Laos
3
Estonia
3
Jordan
3
Jamaica
3
Sri Lanka
3
Somalia
3
Switzerland
2
Turkey
2
Kazakhstan
2
Iran
2
Canada
2
Fiji
2
Kyrgyzstan
2
Saudi Arabia
2
North America
2
Gabon
2
Lebanon
2
Papua New Guinea
2
Central African Republic
2
Poland
2
Angola
2
North Korea
1
Mexico
1
Serbia
1
Australia
1
Gambia
1
Chile
1
Singapore
1
Uzbekistan
1
Malaysia
1
Austria
1
Morocco
1
Mongolia
1
Qatar
1
Bulgaria
1
Hungary
1
Lithuania
1
Ireland
1
Turkmenistan
1
Denmark
1
Belgium
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Portugal
1
Belarus
1
Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Romania
1
Greece
1
Palestine
1
Mali
1
Chad
1
Libya
1
Ecuador
1
Solomon Islands
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
1678
Clinical Guidelines
462
Public Health
198
Women & Child Health
148
Key Resources
87
Capacity Building
58
Pharmacy & Technologies
47
Toolboxes
HIV
642
TB
484
Mental Health
440
AMR
225
NTDs
170
COVID-19
150
Pharmacy
150
NCDs
105
Caregiver
80
Rapid Response
57
Ebola & Marburg
56
Refugee
46
Conflict
42
Disability
41
Planetary Health
28
Global Health Education
26
Polio
17
Health Financing Toolbox
15
Cholera
13
Specific Hazards
11
Natural Hazards
10
Zika
9
Social Ethics
6
Malaria
1
Ivermectin is an antiparasitic drug approved for the treatment of parasitic infections, including strongyloidiasis and onchocerciasis in humans. There is a reported increase in the use of ivermectin for the prevention and treatment of COVID-19 by the public in African Union Member States.
Currently...
Expert Consensus Validation 2018.
This innovative approach aimed at improving and facilitating the screening, prescribing and monitoring of drug therapy for older patients, is currently being further developed in the area of Clinical Pharmacology at the University of Heidelberg in Mannheim. This ap...
The pamphlet "What is Addiction" explains addiction as a chronic, relapsing brain disease characterized by compulsive drug seeking and use, despite harmful consequences. It highlights the dangers of different drug categories, including sedatives, stimulants, and hallucinogens, and their potential he...
We systematically reviewed Medline as well as the references of published review articles for relevant studies of adherence to multidrug treatment of both drug-susceptible and drug-resistant TB through February 3, 2018. We included randomized controlled trials (RCTs) as well as prospective and retro...
sthma prevalence is increasing worldwide, and surveys indicate that most patients in developed and developing countries, including South Africa, do not receive optimal care and are therefore not well controlled. Standard management guidelines adapted to in-country realities are important to support ...
This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of the opportunities for – and threats to – expand...
Co-trimoxazole is a fixed-dose combination of two antimicrobial drugs (sulfamethoxazole and trimethoprim) that covers a variety of bacterial, fungal and protozoan infections. Co-trimoxazole preventive therapy is a feasible, well tolerated and inexpensive intervention for people living with HIV to re...
Antimicrobial resistance represents a big threat to public health. The Centers for Disease Control and Prevention (CDC) estimate that every year two million Americans are infected with a (multi-)drug resistant bacterium, resulting in 23,000 deaths. The WHO has repeatedly drawn attention to this majo...
These guidelines are based on the 3rd Edition of the WHO Guidelines (Published 2015) World Health Organization’s Guidelines for the treatment of malaria. Additional literature surveys have been undertaken. Factors that were considered in the choice of therapeutic options included effectiveness, sa...
Human African Trypanosomiasis (HAT, sleeping sickness) and Animal African Trypanosomiasis (AAT) are neglected tropical diseases generally caused by the same etiological agent, Trypanosoma brucei. Despite important advances in the reduction or disappearance of HAT cases, AAT represents a risky reserv...
Clinical guideline, Methods, Evidence and Recommendations
In this guideline the following is covered: information needs of people with chronic hep
titis B and their carers; where children, young people and adults with chronic hepatitis B a-
should be assessed; assessment of liver disease, includi...
Nat Commun 9, 5370 (2018). https://doi.org/10.1038/s41467-018-07804-8. Mycobacterium ulcerans is the causative agent of Buruli ulcer, a neglected tropical skin disease that is most commonly found in children from West and Central Africa. Despite the severity of the infection, therapeutic options are...
This study was aimed to ascertain the clinical profile and management of patients with ischemic heart disease (IHD) and/or peripheral artery disease (PAD). In this observational and cross-sectional study developed in 80 hospitals throughout Spain, consecutive adults with stable IHD and/or PAD were i...
The mandate of the National Tuberculosis Control Programme is to provide leadership and stewardship to accelerate intense and coordinated efforts to reduce the adult TB burden of 290 per 100,000 population recently established in the 2013 National TB Prevalence Survey. Other key challenges are low T...
After 100 years of chemotherapy with impractical and toxic drugs, an oral cure for human African trypanosomiasis (HAT) is available: Fexinidazole. In this case, we review the history of drug discovery for HAT with special emphasis on the discovery, pre-clinical development, and operational challenge...
Schistosomiasis and soil-transmitted helminths (STH) infections are major public health problems. We aimed to study the 6-mo impact of mass drug administration with praziquantel and albendazole on urinary schistosomiasis and STH.We examined children (aged 2–15 y) from one hamlet, who provided urin...
The Western Pacific Region is the largest and most diverse region in the world, made up of 37 countries and territories in the Pacific, Oceania and parts of Asia, with a population of more than 1.9 billion people stretching over an area from China and Mongolia in the north to New Zealand in the sout...
Cardiovascular disease is a major cause of disability and premature death throughout the world, and contributes substantially to the escalating costs of health care. The underlying pathology is atherosclerosis, which develops over many years and is usually advanced by the time symptoms occur, genera...
Non-communicable diseases (NCDs) pose a substantial threat to many health systems, especially in low-income and middle-income countries (LMICs) where they are already overstretched. In the past few decades, deaths from NCDs in LMICs have spiked, whereas numbers in high-income countries have stabilis...
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the...
